Identification of molecular biomarkers for multiple sclerosis.
暂无分享,去创建一个
Cindy L Vnencak-Jones | Subramaniam Sriram | N. Olsen | T. Aune | P. Crooke | C. Vnencak-Jones | Thomas M Aune | S. Sriram | Nancy J Olsen | Philip S Crooke | Sallyanne C Fossey | Gladys Garrison | Xenquing Deng | S. Fossey | Gladys Garrison | Xenquing Deng
[1] Javed Khan,et al. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. , 2003, Human molecular genetics.
[2] K. Maas,et al. Defective ATM‐p53–mediated apoptotic pathway in multiple sclerosis , 2005, Annals of neurology.
[3] M. Crow,et al. Microarray Analysis of Interferon-regulated Genes in SLE , 2003, Autoimmunity.
[4] J. Todd,et al. A Protective Role of the Environment in the Development of Type 1 Diabetes? , 1991, Diabetic medicine : a journal of the British Diabetic Association.
[5] N. Olsen,et al. Reduced p53 in peripheral blood mononuclear cells from patients with rheumatoid arthritis is associated with loss of radiation-induced apoptosis. , 2005, Arthritis and rheumatism.
[6] T. Aune,et al. Identification of gene expression signatures in autoimmune disease without the influence of familial resemblance. , 2006, Human molecular genetics.
[7] John A Todd,et al. Genetic Analysis of Autoimmune Disease , 1996, Cell.
[8] T. Beaty,et al. Evidence that autoimmunity in man is a Mendelian dominant trait. , 1986, American journal of human genetics.
[9] M. Alarcón‐Riquelme,et al. The genetic basis of systemic lupus erythematosus--knowledge of today and thoughts for tomorrow. , 2004, Human molecular genetics.
[10] Jorge R. Oksenberg,et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis , 2002, Nature Medicine.
[11] Ec Beachler. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003 .
[12] J. Saver,et al. A Quantitative Study , 2005 .
[13] A S Rigby,et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. , 2000, Arthritis and rheumatism.
[14] J. Trent,et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[15] C I Amos,et al. A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. , 2001, American journal of human genetics.
[16] T. Mack,et al. A revised estimate of twin concordance in systemic lupus erythematosus. , 1992, Arthritis and rheumatism.
[17] E. Wakeland,et al. The genetics of complex autoimmune diseases: non-MHC susceptibility genes , 2001, Nature Immunology.
[18] F. Barkhof,et al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis , 1999, Neurology.
[19] C. Bao,et al. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray , 2003, Genes and Immunity.
[20] A. Compston,et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.
[21] P M Matthews,et al. Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis , 2004, Annals of neurology.
[22] A. Theofilopoulos. The basis of autoimmunity: Part II. Genetic predisposition. , 1995, Immunology today.
[23] L. A. Stargell,et al. Mapping and Functional Characterization of the TAF11 Interaction with TFIIA , 2005, Molecular and Cellular Biology.
[24] I. Simon,et al. Systematic analysis of essential yeast TAFs in genome‐wide transcription and preinitiation complex assembly , 2003, The EMBO journal.
[25] N. Olsen,et al. A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells , 2004, Annals of the rheumatic diseases.
[26] Thomas M. Aune,et al. Cutting Edge: Molecular Portrait of Human Autoimmune Disease1 , 2002, The Journal of Immunology.
[27] Xin Lu,et al. Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.
[28] Lawrence Js,et al. A family survey of lupus erythematosus. 1. Heritability. , 1987 .
[29] Virginia Pascual,et al. Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.
[30] C. Martins,et al. A family survey of lupus erythematosus. 1. Heritability. , 1987, The Journal of rheumatology.
[31] Yu Shyr,et al. Shared gene expression profiles in individuals with autoimmune disease and unaffected first-degree relatives of individuals with autoimmune disease. , 2005, Human molecular genetics.
[32] Philippa Marrack,et al. Autoimmune disease: why and where it occurs , 2001, Nature Medicine.
[33] Kaiyu Jiang,et al. Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis , 2003, Arthritis research & therapy.
[34] B E Kendall,et al. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. , 1987, Brain : a journal of neurology.
[35] M. Crow,et al. Microarray analysis of gene expression in lupus , 2003, Arthritis research & therapy.
[36] P. Gregersen,et al. Peripheral blood gene expression profiling in rheumatoid arthritis , 2005, Genes and Immunity.
[37] G. Karypis,et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.